CXCR4 receptor provides therapeutic target for ovarian cancer
Researchers have described a key cellular receptor in the processes of metastasis in ovarian cancer, the findings may lead to the use of CXCR4 inhibitors as a therapeutic target...
List view / Grid view
Researchers have described a key cellular receptor in the processes of metastasis in ovarian cancer, the findings may lead to the use of CXCR4 inhibitors as a therapeutic target...
Screening for tumour cells in the fallopian tubes may help detect the cancer years before it develops further...
Cancer research at the University of Warwick has received a boost thanks to the former Lord Mayor of Coventry Cllr Lindsley Harvard.
Stem cells are among the most energetically activated, migratory and proliferative sub-populations of tumour cells, according to observations by scholars at the Biomedical Research Centre at the University of Salford.
10 July 2016 | By Cold Spring Harbor Laboratory
Researchers at Cold Spring Harbor Laboratory have discovered new insights into signalling events that underlie metastasis in ovarian cancer cells...
29 June 2016 | By Victoria White, Digital Content Producer
Scientists have examined the proteomes of 169 ovarian cancer patients to identify critical proteins expressed by their tumours...
6 May 2016 | By Victoria White, Digital Content Producer
The microRNA miR551b has been shown to impact STAT3 protein levels, contributing to resistance to cell death and increased proliferation of cancer cells...
10 March 2016 | By Victoria White
These findings from a new study suggest that psaptides could serve as a promising template for the development of treatment options directed against ovarian and maybe other cancers...